Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
MATCH Treatment Subprotocol H: Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations Excluding Melanoma and Thyroid Cancer
Study Type: Treatment
Phase: II
NCTID: NCT02465060
Principal Investigator:
Benjamin Powers
A Phase III, Multicenter, Randomized, Open-label, Parallel group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel LN-144, Autologous Tumor-infiltrating Lymphocytes [TIL] Regimen in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy in Participants with Untreated, Unresectable or Metastatic Melanoma
A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneious Melanoma
Study Type: Treatment
Phase: III
NCTID: NCT03860883
Principal Investigator:
Luke Selby